12 September 2022 - Blood cancer patients are urging PHARMAC to fund a medicine that would restore the quality of life of those suffering with the disease.
The charity Myeloma New Zealand started a campaign to press PHARMAC into funding a treatment that has been standard care throughout the OECD for more than five years.